+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prevention and management of coronary artery disease in patients with diabetes mellitus



Prevention and management of coronary artery disease in patients with diabetes mellitus



Acta Medica Indonesiana 41(1): 41-44



Diabetes mellitus (DM) is a common medical problem and a major risk factor for the development of atherosclerotic coronary artery disease (CAD). Coronary artery disease is highly prevalent and is the major cause of morbidity and mortality in diabetic patients. Patients with CAD and prediabetic states should undergo lifestyle modifications aimed at preventing DM. In patients with CAD and DM, routine use of aspirin and an angiotensin-converting enzyme inhibitor (ACE-I)-unless contraindicated or not tolerated-and strict glycemic, blood pressure, and lipid control are strongly recommended. Intense insulin therapy might be needed for glycemic control, and high-dose statin therapy might be needed for lipid control. For blood pressure control, ACE-Is and angiotensin receptor blockers are considered as first-line therapy. The outcomes after revascularization in diabetic patients are usually worse compared with non-diabetic patients. Advances in PCI include the use of drug-eluting stents and adjunctive drug therapies, such as abciximab. Glycemic control is an important determinant of outcome after revascularization in diabetic patients. Improvements in PCI and coronary artery bypass graft surgery are leading to better results in diabetic patients, and clinical trials are presently comparing contemporary PCI with surgery.

(PDF emailed within 1 workday: $29.90)

Accession: 055166890

Download citation: RISBibTeXText

PMID: 19258681


Related references

Management of coronary artery disease in patients with and without diabetes mellitus. Acute management reasonable but secondary prevention unacceptably poor: a report from the Euro Heart Survey on Diabetes and the Heart. European Journal of Cardiovascular Prevention and Rehabilitation 14(1): 28-36, 2007

Management of coronary artery disease in patients with diabetes mellitus. Indian Heart Journal 53(2): 147-154, 2001

Antithrombotic Therapy for Secondary Prevention in Patients With Diabetes Mellitus and Coronary Artery Disease. Circulation Journal 80(4): 791-801, 2016

Management of coronary artery disease in patients with type 2 diabetes mellitus. Current Cardiology Reports 9(4): 264-271, 2007

Lipid management among coronary artery disease patients with diabetes mellitus or advanced age. American Journal of Cardiology 87(5): 646-649, March 1, 2001

Usefulness of sum of the thickness of plaque in the carotid artery for predicting the presence and the extent of the coronary artery disease in patients with type 2 diabetes mellitus without known coronary artery disease. Diabetes Research and Clinical Practice 96(2): 111-118, 2012

Glycaemic control and cardiovascular risk factor management in patients with diabetes with and without coronary artery disease: insights from the diabetes mellitus status in Canada survey. European Heart Journal. Quality of Care & Clinical Outcomes 2(4): 277-284, 2016

Glycemic management in patients with coronary artery disease and prediabetes or type 2 diabetes mellitus. Circulation 129(24): 2567-2573, 2014

Medical management and strategies to prevent coronary artery disease in patients with type 2 diabetes mellitus. Postgraduate Medicine 125(1): 17-33, 2013

Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease. Circulation 109(18): 2197-2202, 2004

Limited application of prevention measures in patients with diabetes mellitus type 2 and coronary artery disease in Spain. DIETRIC study. Revista Clinica Espanola 205(1): 14-18, 2005

Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial. Circulation 121(10): 1176-1187, 2010

Coagulation status in coronary artery disease patients with type II diabetes mellitus compared with non-diabetic coronary artery disease patients using the PFA-100® and ROTEM®. Platelets 21(8): 616-622, 2011

Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting. Coronary Artery Disease 23(5): 322-329, 2012

Comparison of 30-day outcome, resource use, and coronary artery disease severity in patients with suspected coronary artery disease with and without diabetes mellitus assigned to chest pain units. American Journal of Cardiology 91(10): 1228-1230, 2003